SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001005477-00-003263
Filing Date
2000-04-19
Accepted
2000-04-19 00:00:00
Documents
1
Period of Report
2000-05-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT DEF 14A 80850
  Complete submission text file 0001005477-00-003263.txt   82277
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22570 | Film No.: 604632
SIC: 2833 Medicinal Chemicals & Botanical Products